See more : Immunocore Holdings plc (IMCR) Income Statement Analysis – Financial Results
Complete financial analysis of Dazed, Inc. (MEDH) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Dazed, Inc., a leading company in the Tobacco industry within the Consumer Defensive sector.
- Maire Tecnimont S.p.A. (3OY1.F) Income Statement Analysis – Financial Results
- Leviathan Gold Ltd. (LVXFF) Income Statement Analysis – Financial Results
- Nihon Kagaku Sangyo Co., Ltd. (4094.T) Income Statement Analysis – Financial Results
- China Sinostar Group Company Limited (0485.HK) Income Statement Analysis – Financial Results
- Sigma Labs Inc. Warrant (SGLBW) Income Statement Analysis – Financial Results
Dazed, Inc. (MEDH)
About Dazed, Inc.
Dazed, Inc. focuses on retail, distribution, hospitality, licensing, and franchising of portfolio of counterculture brands. The company was formerly known as MedX Holdings, Inc. and changed its name to Dazed, Inc. in October 2022. Dazed, Inc. was founded in 2004 and is based in Cheyenne, Wyoming.
Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2008 | 2007 | 2006 |
---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 0.00 | 0.00 | 0.00 | 1.48M | 2.18M | 724.82K | 0.00 | 0.00 | 752.15K | 83.68K | 0.00 |
Cost of Revenue | 0.00 | 0.00 | 7.50K | 659.27K | 549.03K | 239.90K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | 0.00 | 0.00 | -7.50K | 821.46K | 1.63M | 484.93K | 0.00 | 0.00 | 752.15K | 83.68K | 0.00 |
Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 55.48% | 74.77% | 66.90% | 0.00% | 0.00% | 100.00% | 100.00% | 0.00% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 261.81 | 57.09 | 0.00 | 0.00 | 5.97M | 0.00 | 0.00 |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 711.55K | 57.03K | 0.00 | 0.00 | 5.26M | 0.00 | 0.00 |
SG&A | 0.00 | 0.00 | 54.49K | 513.58K | 711.81K | 57.09K | 177.95K | 290.75 | 11.23M | 8.07M | 16.99K |
Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating Expenses | 0.00 | 0.00 | 54.49K | 513.58K | 711.81K | 57.09K | 177.95K | 290.75 | 11.23M | 8.07M | 16.99K |
Cost & Expenses | 0.00 | 0.00 | 61.99K | 1.17M | 1.26M | 296.98K | 177.95K | 290.75 | 11.23M | 8.07M | 16.99K |
Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 3.00 | 1.78 | 0.00 | 0.00 | 138.00K | 86.97K | 0.00 |
Interest Expense | 0.00 | 0.00 | 105.27K | 1.78K | 0.00 | 0.00 | 844.51 | 0.00 | 0.00 | 0.00 | 0.00 |
Depreciation & Amortization | 228.49K | 236.56K | 7.50K | 12.10K | 12.20K | -427.84 | 0.00 | 0.00 | 20.74K | 4.56K | -33.97K |
EBITDA | 0.00 | 0.00 | -2.62M | -796.36K | 927.29K | 427.84K | -177.95K | -290.00 | -10.46M | -7.98M | -16.99K |
EBITDA Ratio | 0.00% | 0.00% | 0.00% | 21.61% | 42.62% | 59.03% | 0.00% | 0.00% | -1,327.30% | -9,476.81% | 0.00% |
Operating Income | 0.00 | 0.00 | -61.99K | 307.88K | 915.09K | 427.84K | -177.95K | -290.00 | 10.48M | 7.99M | 16.99K |
Operating Income Ratio | 0.00% | 0.00% | 0.00% | 20.79% | 42.06% | 59.03% | 0.00% | 0.00% | 1,393.04% | 9,542.83% | 0.00% |
Total Other Income/Expenses | 0.00 | 0.00 | -2.68M | -1.12M | -18.54K | -1.78K | -146.75K | -0.75 | -335.79K | 36.28K | 0.00 |
Income Before Tax | 0.00 | 0.00 | -2.74M | -810.25K | 896.56K | 426.06K | -324.70K | -290.75 | 10.00M | 7.93M | 0.00 |
Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | -54.72% | 41.20% | 58.78% | 0.00% | 0.00% | 1,330.05% | 9,482.25% | 0.00% |
Income Tax Expense | 0.00 | 0.00 | 0.00 | -4.00 | 2.00 | 427.84 | 0.00 | 0.00 | 335.79K | -36.28K | 33.97K |
Net Income | 0.00 | 0.00 | -2.74M | -810.25K | 896.56K | 426.06K | -324.70K | -290.75 | -10.81M | -7.95M | -16.99K |
Net Income Ratio | 0.00% | 0.00% | 0.00% | -54.72% | 41.20% | 58.78% | 0.00% | 0.00% | -1,437.69% | -9,499.47% | 0.00% |
EPS | 0.00 | 0.00 | -0.03 | -0.01 | 0.01 | 0.00 | -0.01 | 0.00 | -63.10 | -69.25 | -0.20 |
EPS Diluted | 0.00 | 0.00 | -0.03 | -0.01 | 0.01 | 0.00 | -0.01 | 0.00 | -63.10 | -69.25 | -0.20 |
Weighted Avg Shares Out | 0.00 | 0.00 | 98.50M | 93.56M | 115.98M | 112.61M | 28.07M | 25.37M | 171.36K | 114.79K | 85.00K |
Weighted Avg Shares Out (Dil) | 0.00 | 0.00 | 98.50M | 93.56M | 115.98M | 112.61M | 61.81M | 73.57M | 171.36K | 114.79K | 85.00K |
MedX Holdings, Inc. (MEDH) Resumes Trading on the OTC Markets, Emerges from Expert Market Dormancy
MedX Holdings Inc. strengthens its vertical and acquires Craft Herbs LLC., a licensed hemp cultivator in South Texas
MedX Holdings Inc. continues to grow and Acquires Counterculture Brands Inc. a cannabis licensing and franchising company
MedX Holdings Inc. Acquires Dazed Inc., to Expand into Cannabis Retail and Public Consumption
MedX Holdings Inc. Discusses its Plans to Build Unique Cannabis Lounges in Audio Interview with SmallCapVoice.com
Hans Enriquez, CEO and President of MedX Holdings, Inc., Discusses Hemp Farming & Cannabis Outlook for USA in New Audio Interview with SmallCapVoice.com
The Next Frontier for Pot Stocks (OTC US: GRWG) (OTC US: MEDH) (NASDAQ: APHA)
MedX Holdings Inc. Acquires Smart Brands Digital to Manage Brand Visibility
MedX Holdings Inc. Provides 2021 Update and Outlook Ahead of Cannabis Legislative Changes
MedX Holdings Inc. Provides Year End Shareholder Update
Source: https://incomestatements.info
Category: Stock Reports